{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,14]],"date-time":"2026-05-14T19:12:46Z","timestamp":1778785966467,"version":"3.51.4"},"reference-count":48,"publisher":"Oxford University Press (OUP)","issue":"1","license":[{"start":{"date-parts":[[2024,1,12]],"date-time":"2024-01-12T00:00:00Z","timestamp":1705017600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"funder":[{"DOI":"10.13039\/501100021771","name":"Student Research Committee","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100021771","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003970","name":"Isfahan University of Medical Sciences","doi-asserted-by":"publisher","award":["1402126"],"award-info":[{"award-number":["1402126"]}],"id":[{"id":"10.13039\/501100003970","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,1,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:title>Context<\/jats:title>\n                  <jats:p>Clinical evidence from investigations of the effects of curcumin on liver enzymes in patients with nonalcoholic fatty liver disease (NAFLD) have led to inconsistent results.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Objective<\/jats:title>\n                  <jats:p>The aim of this systematic review and meta-analysis was to investigate the overall effects of curcumin and curcumin plus piperine supplementation on liver enzymes such as alanine aminotransferase (ALT), alkaline phosphatase (ALP), and aspartate aminotransferase (AST) in patients with NAFLD.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Data Sources<\/jats:title>\n                  <jats:p>The Scopus, Web of Science, PubMed, and Cochrane Library databases were searched from inception through July 2023, using search terms representing NAFLD and liver enzymes. Articles were screened independently by 2 researchers based on PICOS inclusion criteria.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Data Extraction<\/jats:title>\n                  <jats:p>The following data were extracted: first author\u2019s name, study location, year of publication, mean age, study duration, study design, participants\u2019 sex, number of participants in each group, dose of curcumin supplementation, and ALT, ALP, and AST concentrations. Risk of bias was assessed using the Cochrane Collaboration\u2019s modified risk-of-bias tool.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Data Analysis<\/jats:title>\n                  <jats:p>Fixed- or random-effects meta-analysis was performed to estimate the effects of curcumin on liver enzymes, considering heterogeneity across studies. The I2 and Cochran\u2019s Q tests were used to assess heterogeneity between studies.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>Overall, 15 randomized controlled trials comprising 905 participants were eligible for this meta-analysis. Curcumin supplementation significantly reduced ALT (weighted mean difference [WMD], \u20134.10, 95%CI, \u20137.16 to \u20131.04) and AST (WMD, \u20133.27; 95%CI, \u20135.16 to \u20131.39), but not ALP (WMD, \u20130.49; 95%CI, \u20131.79 to 0.82). Curcumin plus piperine supplementation had no significant effect on ALT (WMD, \u20133.79; 95%CI, \u201313.30 to 5.72), and AST (WMD, \u20131.1; 95%CI, \u20133.32 to 1.09).<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusions<\/jats:title>\n                  <jats:p>Curcumin supplementation improved AST and ALT levels compared with the control group. However, better-designed randomized controlled trials with larger sample sizes and of higher quality are needed to assess the effects of curcumin on ALP.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Systematic Review Registration<\/jats:title>\n                  <jats:p>PROSPERO registration no. CRD42023448231.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1093\/nutrit\/nuad166","type":"journal-article","created":{"date-parts":[[2023,12,16]],"date-time":"2023-12-16T07:49:35Z","timestamp":1702712975000},"page":"1-12","source":"Crossref","is-referenced-by-count":13,"title":["Curcumin supplementation effect on liver enzymes in patients with nonalcoholic fatty liver disease: a GRADE-assessed systematic review and dose\u2013response meta-analysis of randomized controlled trials"],"prefix":"10.1093","volume":"83","author":[{"given":"Mahdi","family":"Vajdi","sequence":"first","affiliation":[{"name":"Student Research Committee, Isfahan University of Medical Sciences , Isfahan,","place":["Iran"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3023-1681","authenticated-orcid":false,"given":"Shirin","family":"Hassanizadeh","sequence":"additional","affiliation":[{"name":"Student Research Committee, Isfahan University of Medical Sciences , Isfahan,","place":["Iran"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Reza","family":"Hassanizadeh","sequence":"additional","affiliation":[{"name":"Department of Sports Physiology, Faculty of Sports Sciences, Isfahan (Khorasgan) Branch, Islamic Azad University , Isfahan,","place":["Iran"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5861-6129","authenticated-orcid":false,"given":"Mohammad","family":"Bagherniya","sequence":"additional","affiliation":[{"name":"Department of Community Nutrition, School of Nutrition and Food Science, Nutrition and Food Security Research Center, Isfahan University of Medical Sciences , Isfahan,","place":["Iran"]}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2024,1,12]]},"reference":[{"key":"2024121109571664500_nuad166-B1","doi-asserted-by":"crossref","first-page":"942","DOI":"10.1111\/apt.17158","article-title":"The epidemiologic burden of non-alcoholic fatty liver disease across the world","volume":"56","author":"Henry","year":"2022","journal-title":"Aliment Pharmacol Ther"},{"key":"2024121109571664500_nuad166-B2","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1136\/flgastro-2014-100432","article-title":"Non-alcoholic fatty liver disease is associated with higher levels of objectively measured sedentary behaviour and lower levels of physical activity than matched healthy controls","volume":"6","author":"Hallsworth","year":"2015","journal-title":"Frontline Gastroenterol"},{"key":"2024121109571664500_nuad166-B3","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1111\/apt.15673","article-title":"Modelling NAFLD disease burden in four Asian regions\u20142019-2030","volume":"51","author":"Estes","year":"2020","journal-title":"Aliment Pharmacol Ther"},{"key":"2024121109571664500_nuad166-B4","first-page":"505","article-title":"Expression of fatty acid synthase in nonalcoholic fatty liver disease","volume":"3","author":"Dorn","year":"2010","journal-title":"Int J Clin Exp Pathol"},{"key":"2024121109571664500_nuad166-B5","doi-asserted-by":"crossref","first-page":"16041","DOI":"10.1038\/nrdp.2016.41","article-title":"Acute-on-chronic liver failure in cirrhosis","volume":"2","author":"Arroyo","year":"2016","journal-title":"Nat Rev Dis Primers"},{"key":"2024121109571664500_nuad166-B6","doi-asserted-by":"crossref","first-page":"708959","DOI":"10.3389\/fimmu.2021.708959","article-title":"Crosstalk between plasma cytokines, inflammation, and liver damage as a new strategy to monitoring NAFLD progression","volume":"12","author":"Fontes-Cal","year":"2021","journal-title":"Front Immunol"},{"key":"2024121109571664500_nuad166-B7","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1002\/hep.21327","article-title":"Long-term follow-up of patients with NAFLD and elevated liver enzymes","volume":"44","author":"Ekstedt","year":"2006","journal-title":"Hepatology"},{"key":"2024121109571664500_nuad166-B8","first-page":"9338","article-title":"Role of diet and lifestyle changes in nonalcoholic fatty liver disease","volume":"20","author":"Nseir","year":"2014","journal-title":"World J Gastroenterol"},{"key":"2024121109571664500_nuad166-B9","first-page":"e9018","article-title":"Vitamin E as an adjuvant treatment for non-alcoholic fatty liver disease in adults: a systematic review of randomized controlled trials","volume":"12","author":"Usman","year":"2020","journal-title":"Cureus"},{"key":"2024121109571664500_nuad166-B10","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.apsb.2019.11.017","article-title":"Herbal drug discovery for the treatment of nonalcoholic fatty liver disease","volume":"10","author":"Yan","year":"2020","journal-title":"Acta Pharm Sin B"},{"key":"2024121109571664500_nuad166-B11","doi-asserted-by":"crossref","first-page":"172","DOI":"10.2174\/1573408018666220602091615","article-title":"Antioxidant activity and inhibitory effect of curcumin on some enzymes involved in several diseases: acetylcholinesterase, butyrylcholinesterase, \u03b1-glucosidase and tyrosinase","volume":"18","author":"Bisset","year":"2022","journal-title":"CEI"},{"key":"2024121109571664500_nuad166-B12","first-page":"1","article-title":"Effects of nonlinear resistance training with curcumin supplement on liver enzymes in men with non-alcoholic fatty liver disease","volume":"3","author":"Moradi Kelardeh","year":"2017","journal-title":"Rep Health Care"},{"key":"2024121109571664500_nuad166-B13","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1080\/07315724.2016.1267597","article-title":"Turmeric supplementation improves serum glucose indices and leptin levels in patients with nonalcoholic fatty liver diseases","volume":"36","author":"Navekar","year":"2017","journal-title":"J Am Coll Nutr"},{"key":"2024121109571664500_nuad166-B14","doi-asserted-by":"crossref","first-page":"1163950","DOI":"10.3389\/fnut.2023.1163950","article-title":"The effect of curcumin on anthropometric indices, blood pressure, lipid profiles, fasting blood glucose, liver enzymes, fibrosis, and steatosis in non-alcoholic fatty livers","volume":"10","author":"Safari","year":"2023","journal-title":"Front Nutr"},{"key":"2024121109571664500_nuad166-B15","first-page":"3640","article-title":"Turmeric supplementation in nonalcoholic fatty liver disease","volume":"20","author":"Husain","year":"2020","journal-title":"Plant Arch"},{"key":"2024121109571664500_nuad166-B16","first-page":"615","article-title":"Effect of nano-micelle curcumin on hepatic enzymes: a new treatment approach for non-alcoholic fatty liver disease (NAFLD)","volume":"13","author":"Beheshti Namdar","year":"2023","journal-title":"Avicenna J Phytomed"},{"key":"2024121109571664500_nuad166-B17","doi-asserted-by":"crossref","first-page":"2217","DOI":"10.1002\/ptr.7764","article-title":"Efficacy of curcumin plus piperine co-supplementation in moderate-to-high hepatic steatosis: a double-blind, randomized, placebo-controlled clinical trial","volume":"37","author":"Sharifi","year":"2023","journal-title":"Phytother Res"},{"key":"2024121109571664500_nuad166-B18","doi-asserted-by":"crossref","first-page":"102952","DOI":"10.1016\/j.ctim.2023.102952","article-title":"Effects of curcumin\/turmeric supplementation on liver function in adults: a GRADE-assessed systematic review and dose\u2013response meta-analysis of randomized controlled trials","volume":"74","author":"Dehzad","year":"2023","journal-title":"Complement Ther Med"},{"key":"2024121109571664500_nuad166-B19","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/2046-4053-4-1","article-title":"Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015 statement","volume":"4","author":"Moher","year":"2015","journal-title":"Syst Rev"},{"key":"2024121109571664500_nuad166-B20","doi-asserted-by":"crossref","first-page":"d5928","DOI":"10.1136\/bmj.d5928","article-title":"The Cochrane Collaboration\u2019s tool for assessing risk of bias in randomised trials","volume":"343","author":"Higgins","year":"2011","journal-title":"BMJ."},{"key":"2024121109571664500_nuad166-B21","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1136\/bmj.39489.470347.AD","article-title":"GRADE: an emerging consensus on rating quality of evidence and strength of recommendations","volume":"336","author":"Guyatt","year":"2008","journal-title":"BMJ."},{"key":"2024121109571664500_nuad166-B22","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.cegh.2019.05.004","article-title":"Methods of estimating the pooled effect size under meta-analysis: a comparative appraisal","volume":"8","author":"Pathak","year":"2020","journal-title":"Clinical Epidemiology and Global Health"},{"key":"2024121109571664500_nuad166-B23","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1136\/bmj.327.7414.557","article-title":"Measuring inconsistency in meta-analyses","volume":"327","author":"Higgins","year":"2003","journal-title":"BMJ"},{"key":"2024121109571664500_nuad166-B24","doi-asserted-by":"crossref","DOI":"10.1002\/9781119099369","volume-title":"Systematic Reviews in Health Research: Meta-Analysis in Context","author":"Egger","year":"2022"},{"key":"2024121109571664500_nuad166-B25","doi-asserted-by":"crossref","first-page":"1224","DOI":"10.1038\/s41430-018-0386-5","article-title":"A pilot study of the effect of phospholipid curcumin on serum metabolomic profile in patients with non-alcoholic fatty liver disease: a randomized, double-blind, placebo-controlled trial","volume":"73","author":"Chashmniam","year":"2019","journal-title":"Eur J Clin Nutr"},{"key":"2024121109571664500_nuad166-B26","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1186\/s12986-019-0331-1","article-title":"Nano-curcumin improves glucose indices, lipids, inflammation, and nesfatin in overweight and obese patients with non-alcoholic fatty liver disease (NAFLD): a double-blind randomized placebo-controlled clinical trial","volume":"16","author":"Jazayeri-Tehrani","year":"2019","journal-title":"Nutr Metab (Lond)"},{"key":"2024121109571664500_nuad166-B27","first-page":"11","article-title":"Curcumin and piperine combination for the treatment of patients with non-alcoholic fatty liver disease: a double-blind randomized placebo-controlled trial","volume":"1328","author":"Mirhafez","year":"2021","journal-title":"Nat Prod Hum Dis"},{"key":"2024121109571664500_nuad166-B28","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1055\/s-0043-100019","article-title":"Efficacy and safety of phytosomal curcumin in non-alcoholic fatty liver disease: a randomized controlled trial","volume":"67","author":"Panahi","year":"2017","journal-title":"Drug Res (Stuttg)"},{"key":"2024121109571664500_nuad166-B29","doi-asserted-by":"crossref","first-page":"15989","DOI":"10.1002\/jcb.28877","article-title":"Curcuminoids plus piperine improve nonalcoholic fatty liver disease: a clinical trial","volume":"120","author":"Panahi","year":"2019","journal-title":"J Cell Biochem"},{"key":"2024121109571664500_nuad166-B30","doi-asserted-by":"crossref","first-page":"1540","DOI":"10.1002\/ptr.5659","article-title":"Treatment of non-alcoholic fatty liver disease with curcumin: a randomized placebo-controlled trial","volume":"30","author":"Rahmani","year":"2016","journal-title":"Phytother Res"},{"key":"2024121109571664500_nuad166-B31","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1038\/s41430-018-0382-9","article-title":"The effects of curcumin supplementation on liver enzymes, lipid profile, glucose homeostasis, and hepatic steatosis and fibrosis in patients with non-alcoholic fatty liver disease","volume":"73","author":"Saadati","year":"2019","journal-title":"Eur J Clin Nutr"},{"key":"2024121109571664500_nuad166-B32","doi-asserted-by":"crossref","first-page":"102322","DOI":"10.1016\/j.ctim.2020.102322","article-title":"Effects of curcuminoids on inflammatory status in patients with non-alcoholic fatty liver disease: a randomized controlled trial","volume":"49","author":"Saberi-Karimian","year":"2020","journal-title":"Complement Ther Med"},{"key":"2024121109571664500_nuad166-B33","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/j.jbmt.2020.02.021","article-title":"Effects of non-linear resistance training and curcumin supplementation on the liver biochemical markers levels and structure in older women with non-alcoholic fatty liver disease","volume":"24","author":"Kelardeh","year":"2020","journal-title":"J Bodyw Mov Ther"},{"key":"2024121109571664500_nuad166-B34","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.addr.2018.09.003","article-title":"Challenges and innovations of drug delivery in older age","volume":"135","author":"Khan","year":"2018","journal-title":"Adv Drug Deliv Rev"},{"key":"2024121109571664500_nuad166-B35","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1159\/000065506","article-title":"Aging liver: a review","volume":"48","author":"Anantharaju","year":"2002","journal-title":"Gerontology"},{"key":"2024121109571664500_nuad166-B36","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.biopha.2016.11.098","article-title":"Phytosomal curcumin: a review of pharmacokinetic, experimental and clinical studies","volume":"85","author":"Mirzaei","year":"2017","journal-title":"Biomed Pharmacother"},{"key":"2024121109571664500_nuad166-B37","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1002\/biof.1932","article-title":"Effect of nano-curcumin on various diseases: a comprehensive review of clinical trials","volume":"49","author":"Hassanizadeh","year":"2023","journal-title":"Biofactors"},{"key":"2024121109571664500_nuad166-B38","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1186\/s40360-020-00440-3","article-title":"The anti-apoptotic, antioxidant and anti-inflammatory effects of curcumin on acrylamide-induced neurotoxicity in rats","volume":"21","author":"Guo","year":"2020","journal-title":"BMC Pharmacol Toxicol"},{"key":"2024121109571664500_nuad166-B39","doi-asserted-by":"crossref","first-page":"111888","DOI":"10.1016\/j.biopha.2021.111888","article-title":"Pharmacological properties and underlying mechanisms of curcumin and prospects in medicinal potential","volume":"141","author":"Fu","year":"2021","journal-title":"Biomed Pharmacother"},{"key":"2024121109571664500_nuad166-B40","doi-asserted-by":"crossref","first-page":"1608","DOI":"10.5114\/aoms.2018.73596","article-title":"The role of curcumin in liver diseases","volume":"15","author":"Buonomo","year":"2019","journal-title":"Arch Med Sci"},{"key":"2024121109571664500_nuad166-B41","doi-asserted-by":"crossref","first-page":"5463","DOI":"10.1111\/febs.16336","article-title":"Nrf2 and oxidative stress in liver ischemia\/reperfusion injury","volume":"289","author":"G. Bardallo","year":"2022","journal-title":"Febs J"},{"key":"2024121109571664500_nuad166-B42","doi-asserted-by":"crossref","first-page":"1457","DOI":"10.1111\/j.1478-3231.2009.02086.x","article-title":"Pharmacological actions of curcumin in liver diseases or damage","volume":"29","author":"Rivera-Espinoza","year":"2009","journal-title":"Liver Int"},{"key":"2024121109571664500_nuad166-B43","doi-asserted-by":"crossref","first-page":"4234061","DOI":"10.1155\/2016\/4234061","article-title":"Insights into the role and interdependence of oxidative stress and inflammation in liver diseases","volume":"2016","author":"Li","year":"2016","journal-title":"Oxid Med Cell Longev"},{"key":"2024121109571664500_nuad166-B44","doi-asserted-by":"crossref","first-page":"1755","DOI":"10.1080\/10408398.2021.1968786","article-title":"Current insights into epigenetics, noncoding RNA interactome and clinical pharmacokinetics of dietary polyphenols in cancer chemoprevention","volume":"63","author":"Shah","year":"2023","journal-title":"Crit Rev Food Sci Nutr"},{"key":"2024121109571664500_nuad166-B45","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1111\/bcpt.12076","article-title":"Curcumin attenuates diet-induced hepatic steatosis by activating AMP-activated protein kinase","volume":"113","author":"Um","year":"2013","journal-title":"Basic Clin Pharmacol Toxicol"},{"key":"2024121109571664500_nuad166-B46","doi-asserted-by":"crossref","first-page":"1352","DOI":"10.1111\/j.1476-5381.2009.00335.x","article-title":"Curcumin adds spice to the debate: lipid metabolism in liver disease","volume":"157","author":"Graham","year":"2009","journal-title":"Br J Pharmacol"},{"key":"2024121109571664500_nuad166-B47","doi-asserted-by":"crossref","first-page":"1354","DOI":"10.1111\/j.1476-5381.2009.00261.x","article-title":"Curcumin suppresses expression of low-density lipoprotein (LDL) receptor, leading to the inhibition of LDL-induced activation of hepatic stellate cells","volume":"157","author":"Kang","year":"2009","journal-title":"Br J Pharmacol"},{"key":"2024121109571664500_nuad166-B48","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1038\/sj.bjp.0707542","article-title":"Curcumin inhibits connective tissue growth factor gene expression in activated hepatic stellate cells in vitro by blocking NF-\u03baB and ERK signalling","volume":"153","author":"Chen","year":"2008","journal-title":"Br J Pharmacol"}],"container-title":["Nutrition Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/nutritionreviews\/article-pdf\/83\/1\/1\/61007510\/nuad166.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/nutritionreviews\/article-pdf\/83\/1\/1\/61007510\/nuad166.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,12,11]],"date-time":"2024-12-11T10:16:39Z","timestamp":1733912199000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/nutritionreviews\/article\/83\/1\/1\/7517275"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,1,12]]},"references-count":48,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,1,12]]},"published-print":{"date-parts":[[2025,1,1]]}},"URL":"https:\/\/doi.org\/10.1093\/nutrit\/nuad166","relation":{},"ISSN":["0029-6643","1753-4887"],"issn-type":[{"value":"0029-6643","type":"print"},{"value":"1753-4887","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2025,1]]},"published":{"date-parts":[[2024,1,12]]}}}